SEC Form 4 · accession 0001209191-18-045506

LEMAITRE VASCULAR INC · LMAT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President and Director · Director

Period of report

Aug 2, 2018

Accepted (ET)

Aug 6, 2018 · 4:06 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001158895

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Aug 2, 2018	S	21,005	$35.7202	D	5,373	D
Common Stock^F2	Aug 3, 2018	M	8,575	$7.87	A	13,948	D
Common Stock^F2	Aug 3, 2018	M	9,752	$11.43	A	23,700	D
Common Stock^F2	Aug 3, 2018	M	10,009	$14.13	A	33,709	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$7.87	Aug 3, 2018	M	8,575	D	Jul 24, 2014	Jul 24, 2021	Common Stock	8,575	8,574	D
Stock Option (Right to Buy)^F3	$11.43	Aug 3, 2018	M	9,752	D	Jul 23, 2015	Jul 23, 2022	Common Stock	9,752	19,503	D
Stock Option (Right to Buy)^F3	$14.13	Aug 3, 2018	M	10,009	D	Jul 25, 2016	Jul 25, 2023	Common Stock	10,009	25,787	D

F1The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $35.50 to $35.96. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F2Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F3This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.